BACKGROUND: Infants born to HIV-infected women should receive HIV testing to allow early diagnosis and treatment. Recommendations for resource-limited settings stress laboratory-based virologic assays. While effective, these tests are logistically complex and expensive. This study explored the cost-effectiveness of incorporating initial screening with rapid HIV tests (RHT) into the conventional testing algorithm to screen-out HIV-uninfected infants, thereby reducing the need for costly virologic testing. METHODS: Data on HIV prevalence, RHT sensitivity and specificity, and costs were collected from 820 HIV-exposed children (1.5-18 months) attending 2 postnatal screening programs in Uganda during July 2005 to December 2006. Cost-effectiveness models compared the conventional testing algorithm DNA polymerase chain reaction (DNA-PCR with Roche Amplicor v1.5) with a modified algorithm (initial RHT to screen-out HIV-uninfected infants before DNA-PCR). RESULTS: The model estimated that the conventional algorithm would identify 94.3% (91.8%-94.7%) of HIV-infected infants, compared with 87.8% (79.4%-90.5%) for a modified algorithm using RHT (HIV 1/2 Determine) and excluding the need for DNA-PCR for HIV antibody-negative infants. Costs per infant were $23.47 ($23.32-$23.76) for the conventional algorithm and between $22.75 ($21.89-$23.31) and $7.58 ($6.41-$10.75) for the modified algorithm, depending on infant age and symptoms. Compared with the conventional algorithm, costs per HIV-infected infant identified using the modified algorithm were higher in 1.5-to 3-month-old infants, but significantly lower in 3-month-old and older infants. Models replicating the whole infant testing program showed the modified algorithm would have marginally lower sensitivity, but would reduce total program costs by 27% to 40%, producing an incremental cost-effectiveness ratio of $1489 ($686-$6781) for the conventional versus modified algorithms. CONCLUSIONS: Screening infants with RHT before DNA-PCR is cost-effective in infants 3 months old or older. Incorporating RHT into early infant testing programs could improve cost-effectiveness and reduce program costs.
BACKGROUND:Infants born to HIV-infectedwomen should receive HIV testing to allow early diagnosis and treatment. Recommendations for resource-limited settings stress laboratory-based virologic assays. While effective, these tests are logistically complex and expensive. This study explored the cost-effectiveness of incorporating initial screening with rapid HIV tests (RHT) into the conventional testing algorithm to screen-out HIV-uninfectedinfants, thereby reducing the need for costly virologic testing. METHODS: Data on HIV prevalence, RHT sensitivity and specificity, and costs were collected from 820 HIV-exposed children (1.5-18 months) attending 2 postnatal screening programs in Uganda during July 2005 to December 2006. Cost-effectiveness models compared the conventional testing algorithm DNA polymerase chain reaction (DNA-PCR with Roche Amplicor v1.5) with a modified algorithm (initial RHT to screen-out HIV-uninfectedinfants before DNA-PCR). RESULTS: The model estimated that the conventional algorithm would identify 94.3% (91.8%-94.7%) of HIV-infectedinfants, compared with 87.8% (79.4%-90.5%) for a modified algorithm using RHT (HIV 1/2 Determine) and excluding the need for DNA-PCR for HIV antibody-negative infants. Costs per infant were $23.47 ($23.32-$23.76) for the conventional algorithm and between $22.75 ($21.89-$23.31) and $7.58 ($6.41-$10.75) for the modified algorithm, depending on infant age and symptoms. Compared with the conventional algorithm, costs per HIV-infectedinfant identified using the modified algorithm were higher in 1.5-to 3-month-old infants, but significantly lower in 3-month-old and older infants. Models replicating the whole infant testing program showed the modified algorithm would have marginally lower sensitivity, but would reduce total program costs by 27% to 40%, producing an incremental cost-effectiveness ratio of $1489 ($686-$6781) for the conventional versus modified algorithms. CONCLUSIONS: Screening infants with RHT before DNA-PCR is cost-effective in infants 3 months old or older. Incorporating RHT into early infant testing programs could improve cost-effectiveness and reduce program costs.
Authors: Anjuli D Wagner; Kate S Wilson; Joseph B Babigumira; Cyrus Mugo; Peter M Mutiti; Jillian Neary; Dalton C Wamalwa; David Bukusi; Grace C John-Stewart; Pamela K Kohler; Jennifer A Slyker Journal: J Assoc Nurses AIDS Care Date: 2020 Jul-Aug Impact factor: 1.354
Authors: Anjuli D Wagner; Irene N Njuguna; Ruth A Andere; Lisa M Cranmer; Helen M Okinyi; Sarah Benki-Nugent; Bhavna H Chohan; Elizabeth Maleche-Obimbo; Dalton C Wamalwa; Grace C John-Stewart Journal: AIDS Date: 2017-07-17 Impact factor: 4.177
Authors: Andrea L Ciaranello; Ji-Eun Park; Lynn Ramirez-Avila; Kenneth A Freedberg; Rochelle P Walensky; Valeriane Leroy Journal: BMC Med Date: 2011-05-20 Impact factor: 8.775
Authors: Kira Elsbernd; Karl M F Emmert-Fees; Amanda Erbe; Veronica Ottobrino; Arne Kroidl; Till Bärnighausen; Benjamin P Geisler; Stefan Kohler Journal: Infect Dis Poverty Date: 2022-07-15 Impact factor: 10.485
Authors: Andrea L Ciaranello; Bethany L Morris; Rochelle P Walensky; Milton C Weinstein; Samuel Ayaya; Kathleen Doherty; Valeriane Leroy; Taige Hou; Sophie Desmonde; Zhigang Lu; Farzad Noubary; Kunjal Patel; Lynn Ramirez-Avila; Elena Losina; George R Seage; Kenneth A Freedberg Journal: PLoS One Date: 2013-12-13 Impact factor: 3.240